These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 230989)

  • 1. [Variations of B- and T-lymphocytes in the peripheral blood and variations of the stimulability of cyclic nucleotides in the T-lymphocytes of patients suffering from malignant melanoma (author's transl)].
    Busse E; Rose H; Lehnert W
    Dermatol Monatsschr; 1979 Sep; 165(9):634-41. PubMed ID: 230989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral blood lymphocytes in melanoma].
    Luchenko IM
    Vopr Onkol; 1977; 23(2):53-6. PubMed ID: 300944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma.
    Bernengo MG; Lisa F; Meregalli M; Doveil GC
    Int J Tissue React; 1984; 6(6):505-11. PubMed ID: 6335712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune profile in melanoma patients. I. PHA--stimulation of circulating lymphocytes and number of T- and B-lymphocytes (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(6):559-64. PubMed ID: 310289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of cyclic nucleotid concentrations in leucocytes and T-cells in patients with skin tumours (author's transl)].
    Busse E; Lehnert W; Rose H
    Dermatol Monatsschr; 1979 Aug; 165(8):575-9. PubMed ID: 229003
    [No Abstract]   [Full Text] [Related]  

  • 7. [Variations of plasmatic cyclic nucleotides in the asthmatic patient (cyclic adenosine monophosphate and cyclic guanosine monophosphate) (author's transl)].
    Clauzel AM; Calvayrac P; Michel FB
    Poumon Coeur; 1980; 36(5):295-302. PubMed ID: 6256723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the level of cyclic nucleotides in three population of human lymphocytes in culture.
    Carpentieri U; Monahan TM; Gustavson LP
    J Cyclic Nucleotide Res; 1980; 6(4):253-9. PubMed ID: 6259221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological aspects of Kaposi's disease].
    Shaposhnikov OK; Karachunova TN
    Vopr Onkol; 1985; 31(12):18-23. PubMed ID: 3002041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of the cyclic nucleotide and calcitonin levels and the cellular immunity indices in true eczema patients].
    Kubanova AA; Vasil'eva LL; Zolotukhin SV; Suchkova ShN
    Vestn Dermatol Venerol; 1984 Jul; (7):16-20. PubMed ID: 6089468
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B lymphocytes in malignant melanoma patients.
    Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
    Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modulation of spontaneous and anti-Ig-stimulated motility of lymphocytes by cyclic nucleotides and adrenergic and cholinergic agents.
    Schreiner GF; Unanue ER
    J Immunol; 1975 Feb; 114(2 pt 2):802-8. PubMed ID: 163280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma].
    Klein R; Krüger GR; Sesterhenn K
    Z Hautkr; 1978 Feb; 53(3):62-6. PubMed ID: 305173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging normal humans and patients with Down's syndrome.
    Tam CF; Walford RL
    J Immunol; 1980 Oct; 125(4):1665-70. PubMed ID: 6106029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The level of cyclic nucleotides and the activity of their phosphodiesterases in the peripheral blood lymphocytes in lung diseases during endolymphatic antibiotic therapy].
    Feshchenko IuI; Spizhenko IuP
    Ter Arkh; 1991; 63(8):7-10. PubMed ID: 1665248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The change of T- and L-lymphocyte count in patients with malignant melanoma (author's transl)].
    Busse E; Rose H
    Radiobiol Radiother (Berl); 1979 Apr; 20(2):239-41. PubMed ID: 314121
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients.
    Bernengo MG; Capella G; de Matteis A; Tovo PA; Zina G
    Clin Exp Immunol; 1979 May; 36(2):279-84. PubMed ID: 314368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age and immunity. I. Lymphocyte populations in the peripheral blood in various age groups (author's transl)].
    Rosenthal M; Steinmann A
    Dtsch Med Wochenschr; 1978 Mar; 103(10):409-12. PubMed ID: 305839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.